N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors
US12343352B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 3, 2020 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Apr 9, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods of treating a hematologic malignancy in a patient in need thereof, comprising administering to the patient a Bcl-2 inhibitor in a step-wise dosing regimen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.